Notice of Clarification to RFA-DA-10-009 (The National Drug Abuse Treatment Clinical Trials Network [U10]): Publication of Frequently Asked Questions (FAQs)

Notice Number: NOT-DA-09-009

Key Dates
Release Date: July 29, 2009

Issued by
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov)

Purpose

The purpose of this notice is to publish the link to a website containing answers to Frequently Asked Questions (FAQs) regarding RFA-DA-10-009 (The National Drug Abuse Treatment Clinical Trials Network [U10]). These FAQs can be viewed at http://www.nida.nih.gov/CTN/RFAFAQ.html. Additional FAQs will be added to this website as they arise.

Inquiries

Inquiries regarding this Notice should be directed to:

Harold I Perl, PhD
Senior Lead for Behavioral Research, Dissemination and Training
Center for the Clinical Trials Network
National Institute on Drug Abuse
6001 Executive Blvd., MSC 9557
Bethesda, MD 20892-9557
Telephone: (301) 443-9982
Fax: (301) 443-2317
E-mail: hperl@nida.nih.gov